All systems operational
Q2 2024

TGF-β1 inhibitor P144 protects against benign restenosis after esophageal stenting through TGF-β1/Smads signaling pathway inhibition

Jun-Zheng Wu · Chun Zhou · Sheng Liu · Jin-Xing Zhang · Wei Yang · Hai-Bin Shi · Wei-Zhong Zhou
10.1016/j.ajg.2024.02.004 388 Views 2 Citations
2
Citations
388
Views
Abstract not available for this publication.
Cite this Article (APA)
Jun-Zheng, W., Chun, Z., Sheng, L., Jin-Xing, Z., Wei, Y., Hai-Bin, S., Wei-Zhong, Z. (2024). TGF-β1 inhibitor P144 protects against benign restenosis after esophageal stenting through TGF-β1/Smads signaling pathway inhibition. Arab Journal of Gastroenterology. https://doi.org/10.1016/j.ajg.2024.02.004
Related Papers
Efficacy of L-ornithine L-aspartate for minimal hepatic encephalopathy in patients with cirrhosis: A…
Qiufeng He; Chuangjie Mao; Zhili Chen; Yilan Zeng; Yang Deng; Rong Hu · 2024
11
cites
391
Chimeric antigen receptor-T cells targeting AFP-GPC3 mediate increased antitumor efficacy in hepatoc…
Mingxing Li; Tailin Chen; Rongshi Huang; Yanhui Cen; Feilan Zhao; Rong Fan; Guoz · 2025
10
cites
393
RETRACTED: miR-129-2-3p inhibits colon cancer cell proliferation by down-regulating the expression o…
Liang Tao; Peng Song; Lihua Shao; Hengfei Gao; Kangkang Ji; Yan Ren; Feng Wang; · 2024
8
cites
391
Access
View Full Text via DOI
Published in
ISSN 1687-1979
Quartile Q2
AMS Score 91
Field Medicine & Health Sciences
Publisher Arab Society of Gastroenterology /
Country 🇪🇬 Egypt
View Journal Profile →
Authors
Publication Details
Year 2024
Language English
Added 23 Jul 2026